Capponi Andrea, Rostagno Carlo
Dipartimento Medicina Sperimentale e Clinica, Università di Firenze, 50134 Firenze, Italy.
Dipartimento Medicina Sperimentale e Clinica, Medicina Interna 3 AOU Careggi, Università di Firenze, Viale Morgagni 85, 50134 Firenze, Italy.
Diagnostics (Basel). 2025 Jun 5;15(11):1435. doi: 10.3390/diagnostics15111435.
Trauma remains a leading cause of death and disability in adults, and about 20% of deaths occur due to intractable bleeding. Trauma-induced coagulopathy (TIC) is a complex hemostatic disorder characterized by an abnormal coagulation response, which can manifest as either a hypo-coagulable state, leading to excessive bleeding, or a hypercoagulable state, resulting in thromboembolic events and multiple organ failure. Early diagnosis and correction of hypocoagulability may be lifesaving. Replacement of coagulation factors using blood components as well as counteracting enhanced fibrinolysis with tranexamic acid in association with a strategy of damage control are the current practices in the management of TIC. Nevertheless, the improved comprehension of the several mechanisms involved in the development of TIC might offer space for a tailored treatment with improvement of clinical outcome. This review aims to outline the pathophysiology of TIC and evaluate both established and emerging management strategies. A thorough literature review was made with a specific emphasis on articles discussing the molecular mechanisms of trauma-induced coagulopathy. We utilized PubMed, Scopus, and Web of Science with the main search terms "trauma-induced coagulopathy", "molecular mechanisms", and "coagulation pathways".
创伤仍然是成人死亡和残疾的主要原因,约20%的死亡是由难以控制的出血所致。创伤性凝血病(TIC)是一种复杂的止血障碍,其特征为凝血反应异常,可表现为低凝状态导致出血过多,或高凝状态导致血栓栓塞事件和多器官功能衰竭。早期诊断和纠正低凝状态可能挽救生命。使用血液成分替代凝血因子以及联合氨甲环酸对抗增强的纤维蛋白溶解并采用损伤控制策略是目前TIC管理中的做法。然而,对TIC发生所涉及的多种机制的深入理解可能为改善临床结局的个体化治疗提供空间。本综述旨在概述TIC的病理生理学,并评估已确立和新出现的管理策略。我们进行了全面的文献综述,特别强调讨论创伤性凝血病分子机制的文章。我们使用了PubMed、Scopus和科学网,主要搜索词为“创伤性凝血病”“分子机制”和“凝血途径”。